Wu Long, Tang Zhao-You, Li Yan
Department of Oncology, Zhongnan Hospital of Wuhan University and Hubei Key Laboratory of Tumour Biological Behaviors, No 169 Donghu Road, Wuchang District, 430071 Wuhan, China.
J Cancer Res Clin Oncol. 2009 Aug;135(8):969-81. doi: 10.1007/s00432-009-0591-7. Epub 2009 Apr 28.
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The biological mechanisms of hepatocarcinogenesis and progression are poorly understood. Experimental models of HCC provide valuable tools to evaluate the risk factors, new treatment modalities and biologic characteristics. Under the constant evolution in model design and technology development, new experimental models continue to emerge, including spontaneous models, induced models, viral models, transplantable models, and genetically engineered models. These models are used as tools to investigate basic biological mechanisms of growth and differentiation, oncogene function, and as systems to test new diagnostic and therapeutic approaches. Each model has its own advantages and disadvantages. The progress in HCC model construction and studies are summarized in this review.
肝细胞癌(HCC)是世界上最常见的恶性肿瘤之一。肝癌发生和进展的生物学机制尚不清楚。HCC实验模型为评估风险因素、新的治疗方式和生物学特性提供了有价值的工具。在模型设计和技术发展不断演进的情况下,新的实验模型不断涌现,包括自发模型、诱导模型、病毒模型、可移植模型和基因工程模型。这些模型被用作研究生长和分化的基本生物学机制、癌基因功能的工具,以及测试新诊断和治疗方法的系统。每种模型都有其自身的优缺点。本文综述了HCC模型构建和研究的进展。